tgaac09
Vaccineexperimental
Clinical trial activity
2 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2003 (NCT00482027)
Timeline
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tgaac09
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00888446 | Phase 2 | Oct 1, 2005 | AmpliPhi Biosciences Corporation, Desmond Tutu HIV Foundation, International AIDS Vaccine Initiative, Medical Research Council, Medical University of Southern Africa, Perinatal HIV Research Unit, Baragwanath, Zambia-Emory HIV Research Project |
| NCT00482027 | Phase 1 | Dec 1, 2003 | AmpliPhi Biosciences Corporation, International AIDS Vaccine Initiative, Ohio State University, St. Pierre University, University of Hamburg, University of Pennsylvania |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AmpliPhi Biosciences Corporation | For profit | 2 | 0 | 2 | 2003 |
| International AIDS Vaccine Initiative | Academic/Hospital | 2 | 2 | 2 | 2003 |
| Desmond Tutu HIV Foundation | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Medical Research Council | Government | 1 | 0 | 1 | 2005 |
| Medical University of Southern Africa | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Ohio State University | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Perinatal HIV Research Unit, Baragwanath | Academic/Hospital | 1 | 0 | 1 | 2005 |
| St. Pierre University | Academic/Hospital | 1 | 0 | 1 | 2003 |
| University of Hamburg | Academic/Hospital | 1 | 0 | 1 | 2003 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Zambia-Emory HIV Research Project | Academic/Hospital | 1 | 0 | 1 | 2005 |
11 organizations
Page 1 / 1